# Spyre Therapeutics (SYRE) — News SYRE · NASDAQ · Stock Canonical page: https://www.lighthorse.io/tickers/syre/news ## Recent headlines - [Agility Robotics and Churchill Capital Corp XI S-4 registration statement declared effective by SEC in connection with proposed business combination](https://www.ainvest.com/news/agility-robotics-churchill-capital-corp-xi-4-registration-statement-declared-effective-sec-connection-proposed-business-combination-2610) — AInvest Wire, Oct 13, 2026 The U.S. Securities and Exchange Commission (SEC) has declared effective the registration statement on Form S-4 filed by Agility Robotics, Inc. and Churchill Capital Corp XI (NASDAQ: CCXI) in connection with their proposed business combination . This development marks a key step toward the… - [Adani Green Generation capacity 20.8 GW at end-Sept, +24% y/y](https://www.ainvest.com/news/adani-green-generation-capacity-20-8-gw-sept-24-2610) — AInvest Wire, Oct 10, 2026 Adani Green Energy Ltd (AGEL) has reported a significant increase in its renewable energy generation capacity, reaching 20.8 gigawatts (GW) as of the end of September 2026, representing a 24% year-over-year growth . This expansion underscores the company’s ongoing commitment to scaling India’s… - [Spyre Therapeutics shares slip 2.8% after co prices $350 million stock offering](https://www.ainvest.com/news/spyre-therapeutics-shares-slip-2-8-prices-350-million-stock-offering-2610) — AInvest Wire, Oct 6, 2026 Spyre Therapeutics, Inc. (Nasdaq: SYRE) announced the pricing of a $350 million public offering of 4,117,648 shares of its common stock at $85.00 per share, with the offering expected to close on or about October 7, 2026, subject to customary conditions . Following the announcement, the company’s… - [Spyre Therapeutics shares slip 1.7% premarket after co prices $350 million stock offering](https://www.ainvest.com/news/spyre-therapeutics-shares-slip-1-7-premarket-prices-350-million-stock-offering-2610) — AInvest Wire, Oct 6, 2026 Spyre Therapeutics Inc. (SPYR) shares declined 1.7% in premarket trading on October 6, 2026, following the company’s announcement of a $350 million stock offering. The offering, which includes the sale of newly issued shares, is intended to support ongoing research and development efforts across… - [Spyre Therapeutics prices $350M offering of stock](https://www.ainvest.com/news/spyre-therapeutics-prices-350m-offering-stock-2610) — AInvest Wire, Oct 6, 2026 Spyre Therapeutics, Inc. (Nasdaq: SYRE) has priced a public offering of 6,500,000 shares of its common stock at $62.00 per share, generating gross proceeds of approximately $403.0 million before underwriting discounts and expenses. The offering, which is expected to close on or about April 16,… --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).